|
Volumn 4, Issue 4, 2005, Pages 207-208
|
Pregabalin for painful neuropathy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DOPAMINE RECEPTOR STIMULATING AGENT;
GABAPENTIN;
OPIATE;
PREGABALIN;
TRICYCLIC ANTIDEPRESSANT AGENT;
ANALGESIA;
AXONAL INJURY;
CLINICAL TRIAL;
COST EFFECTIVENESS ANALYSIS;
DIAGNOSTIC ACCURACY;
DIAGNOSTIC PROCEDURE;
DIZZINESS;
DRUG ACTIVITY;
DRUG EFFICACY;
DRUG RESPONSE;
DRUG SCREENING;
DRUG SPECIFICITY;
DRUG TARGETING;
ELECTRODIAGNOSIS;
HUMAN;
INCIDENCE;
NERVE ENDING;
NERVE FIBER;
NERVE INJURY;
NEUROPATHIC PAIN;
NEUROPATHY;
NEUROPHYSIOLOGY;
NEUROTRANSMISSION;
PATIENT;
PATIENT CARE;
PATIENT COMPLIANCE;
PERIPHERAL EDEMA;
POSTHERPETIC NEURALGIA;
PRESYNAPTIC NERVE;
PREVALENCE;
PRIORITY JOURNAL;
QUALITY OF LIFE;
SCORING SYSTEM;
SENESCENCE;
SENSITIZATION;
SHORT SURVEY;
SOMNOLENCE;
|
EID: 15044345224
PISSN: 14744422
EISSN: None
Source Type: Journal
DOI: 10.1016/S1474-4422(05)70027-2 Document Type: Letter |
Times cited : (12)
|
References (5)
|